Toutes les actualités
Our articles

IMS is hosting its workshops on November 14th and 21st

Join the IMS Workshop about "Nanomedicine for drug delivery and imaging" on November 14th On November 14, IMS invites you to a workshop on nanomedicine for drug delivery and imaging. Led by Dr. Alexandre Detappe and Pr. Dominique Bagnard, this event will feature several experts who will share their research and insights.If you're interested in this event,...

An evaluation result, indicator of excellence

In July 2024, the IMS was given the highest score being an A by the Interdisciplinary Thematic Institutes during its mid-term evaluation. What are the ITI (Interdisciplinary thematic institutes) ? The ITI are the pilar of the research and training evolution of the University of Strasbourg. Lead by an international jury, the midterm evaluation is renewing the 13...

INEDIS call for project

Inedis is the cornerstone of the innovation and technology transfer of the IMS Group. This year, we will notice it ! Actually, the Inedis call for proposal is willing to finance of up to 50K euro maximum several excellent projects dealing with development of active molecules/new concepts in any therapeutic areas, and furthermore : Technological projects/...

Seminar at Okayama University

Dominique bagnard invited as speaker On Thursday, 19 September, Dominique Bagnard will be in Tokyo to give a summary of the "Biotechnologies - Organoids on a chip - Openings to improved drug testing and to reduction of animal sacrifice". The talk will briefly introduce organoids, with focus on what they are and how they can be fabricated.This seminar is open to all,...

Library IMS: the new pharmaceutical revolution

What if you could find all the resources you need to make your research project a real success? It's now possible with the IMS Library, with 578 different compounds in stock and ready to be targeted! What exactly is the IMS library? A collection of chemical compounds designed for use in pharmaceutical research, the IMS library has become an indispensable tool in the...

Biodol Therapeutics raises €7 million to bring its next-generation pain therapy to the clinic!

Biodol Therapeutics, an innovative French start-up founded by Didier Rognan, Research Director at the CNRS, Director of the Laboratoire d'Innovation Thérapeutique and member of Strasbourg's Institut du Médicament, has successfully raised €7 million to advance its next-generation pain therapy into clinical trials.Specializing in the development of cutting-edge pain relief treatments,...

IMS Day – a look back at the event

Welcomed at 9am by a coffee reception in the Bâtiment de la Présidence at the Université de Strasbourg, over 100 people attended the IMS Day on May 6, 2024.This event, hosted by renowned speakers and companies in the field of scientific innovation such as Serendip Innovations and Domain Therapeutics, was an opportunity to bring together researchers, teachers and students, all...

MEDALIS call for projects

A funding opportunity for your research projects! Are you a researcher looking for funding for your innovative project? The IMS is issuing its MEDALIS Call for Projects. 💊 What is the MEDALIS call for projects? For any collaboration involving one of our research laboratories and another research laboratory, the MEDALIS call for projects offers up to...